Clinical Trials Browser

Hematologic Neoplasms × Olanzapine × 90 days × Clear all

NCT04939090 2026-04-13

Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients

Phase 3 Active not recruiting

Other hematologic neoplasm

Anorexia, Hematologic Neoplasms